NCT01670526View on ClinicalTrials.gov

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2017

Conditions
Traumatic Brain InjuryCognitive Impairment
Interventions
DRUG

Rivastigmine Transdermal Patch

Cholinesterase Inhibitor

Trial Locations (8)

33125

Miami VA Healthcare System, Miami, FL, Miami

33612

James A. Haley Veterans' Hospital, Tampa, FL, Tampa

68510

Lincoln Community-Based Outpatient Clinic, Lincoln, NE, Lincoln

77030

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

84148

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City

92161

VA San Diego Healthcare System, San Diego, CA, San Diego

60141-5000

Edward Hines Jr. VA Hospital, Hines, IL, Hines

29401-5799

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01670526 - Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI | Biotech Hunter | Biotech Hunter